Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
The American Journal of Cardiology|February 5, 2003
Functional relevance of aldosterone for the determination of left ventricular massChristian Delles, Bernhard M W Schmidt, Hans J Müller, et al.
Atherosclerosis|June 13, 2006
Effects of nitric oxide synthase inhibition and L-arginine on renal haemodynamics in young patients at high cardiovascular riskMarkus P Schlaich, Sebastian Oehmer, Markus P Schneider, et al.
Leukemia Research Reports|July 17, 2025
Pharmacokinetics and outcome of high-dose melphalan followed by autologous stem cell transplantation in dialysis-dependent patients with multiple myelomaRabea Mecklenbrauck, Bernhard M W Schmidt, Heike Bähre, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 16, 2025
Chronic kidney disease confers increased excess risks of mortality and cardiovascular events in women compared to menZhejia Tian, Uta C Hillebrand, Janis Casper, et al.
American Journal of Hypertension|December 21, 2004
The effect of statins on angiotensin II-induced hemodynamic changes in young, mildly hypercholesterolemic menE H Fleischmann, S John, C Delles, et al.
Atherosclerosis|February 15, 2007
Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemiaChristian Ott, Markus P Schlaich, Bernhard M W Schmidt, et al.
Arthritis Care & Research|July 18, 2013
Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of goutSeoyoung C Kim, Bernhard M W Schmidt, Jessica M Franklin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2000
Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cellsM S Gordon, R M Kato, F Lansigan, et al.
Blood Cells, Molecules & Diseases|June 6, 1998
Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancerH E Broxmeyer, A Orazi, N L Hague, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Nongenomic cardiovascular effects of triiodothyronine in euthyroid male volunteersBernhard M W Schmidt, Nicole Martin, Anette C Georgens, et al.
Pageof 20